DK1200129T3 - Smagsmaskering af orale, flydende quinolonfremstillinger ved anvendelse af ionbytterharpikser - Google Patents

Smagsmaskering af orale, flydende quinolonfremstillinger ved anvendelse af ionbytterharpikser

Info

Publication number
DK1200129T3
DK1200129T3 DK00945340T DK00945340T DK1200129T3 DK 1200129 T3 DK1200129 T3 DK 1200129T3 DK 00945340 T DK00945340 T DK 00945340T DK 00945340 T DK00945340 T DK 00945340T DK 1200129 T3 DK1200129 T3 DK 1200129T3
Authority
DK
Denmark
Prior art keywords
ion exchange
oral liquid
exchange resins
taste masking
quinolone
Prior art date
Application number
DK00945340T
Other languages
Danish (da)
English (en)
Inventor
Rong Gao
Zezhi Jesse Shao
Allan Chor-Lun Fan
Leonore Cat Witchey-Lakshmanan
Daniel Charles Stewart
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Application granted granted Critical
Publication of DK1200129T3 publication Critical patent/DK1200129T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00945340T 1999-07-14 2000-07-12 Smagsmaskering af orale, flydende quinolonfremstillinger ved anvendelse af ionbytterharpikser DK1200129T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35354999A 1999-07-14 1999-07-14
PCT/US2000/018948 WO2001005431A1 (en) 1999-07-14 2000-07-12 Taste masking of oral quinolone liquid preparations using ion exchange resins

Publications (1)

Publication Number Publication Date
DK1200129T3 true DK1200129T3 (da) 2009-01-12

Family

ID=23389610

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00945340T DK1200129T3 (da) 1999-07-14 2000-07-12 Smagsmaskering af orale, flydende quinolonfremstillinger ved anvendelse af ionbytterharpikser

Country Status (24)

Country Link
EP (1) EP1200129B1 (ja)
JP (2) JP2003504416A (ja)
AR (1) AR024715A1 (ja)
AT (1) ATE411047T1 (ja)
AU (1) AU777993B2 (ja)
BG (1) BG65656B1 (ja)
BR (1) BR0012439A (ja)
CA (1) CA2378894C (ja)
CY (1) CY1108801T1 (ja)
CZ (1) CZ302919B6 (ja)
DE (1) DE60040540D1 (ja)
DK (1) DK1200129T3 (ja)
ES (1) ES2313897T3 (ja)
HU (1) HUP0202229A3 (ja)
IL (2) IL147242A0 (ja)
MX (1) MXPA02000501A (ja)
NO (1) NO20020134D0 (ja)
NZ (1) NZ516536A (ja)
PL (1) PL202027B1 (ja)
PT (1) PT1200129E (ja)
SI (1) SI1200129T1 (ja)
SK (1) SK287415B6 (ja)
WO (1) WO2001005431A1 (ja)
ZA (1) ZA200200026B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6589955B2 (en) 2001-06-20 2003-07-08 Bristol-Myers Squibb Company Pediatric formulation of gatifloxacin
DE10224086A1 (de) * 2002-05-31 2003-12-11 Bayer Ag Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker
JP5009707B2 (ja) * 2007-07-10 2012-08-22 東和薬品株式会社 不快な味がマスキングされたキノロン系抗菌剤の経口投与用液剤
ES2588008T3 (es) * 2010-05-19 2016-10-28 Astellas Pharma Inc. Composición farmacéutica que contiene solifenacina

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4788055A (en) * 1985-12-09 1988-11-29 Ciba-Geigy Corporation Resinate sustained release dextromethorphan composition
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
DE3719764A1 (de) * 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
US5275820A (en) * 1990-12-27 1994-01-04 Allergan, Inc. Stable suspension formulations of bioerodible polymer matrix microparticles incorporating drug loaded ion exchange resin particles
DE69224071T2 (de) * 1991-09-17 1998-05-07 Alcon Lab Inc Chinolan-antibiotika und polystyrolsulfonat enthaltende zusammensetzungen
DE69419281T2 (de) * 1993-04-28 2000-03-23 Takeda Chemical Industries Ltd Geschmacksmaskierte feste Zubereitung und Verfahren zur Herstellung
JPH0710747A (ja) * 1993-04-28 1995-01-13 Takeda Chem Ind Ltd 固形製剤およびその製造方法
JP2000103730A (ja) * 1998-07-31 2000-04-11 Otsuka Pharmaceut Co Ltd 服用感が改善された医薬組成物

Also Published As

Publication number Publication date
JP2011246497A (ja) 2011-12-08
IL147242A0 (en) 2002-08-14
EP1200129B1 (en) 2008-10-15
SI1200129T1 (sl) 2009-06-30
AU5930200A (en) 2001-02-05
PL202027B1 (pl) 2009-05-29
DE60040540D1 (de) 2008-11-27
AU777993B2 (en) 2004-11-11
WO2001005431A1 (en) 2001-01-25
PT1200129E (pt) 2008-12-17
HUP0202229A3 (en) 2008-10-28
SK287415B6 (sk) 2010-09-07
BG106329A (en) 2002-08-30
ES2313897T3 (es) 2009-03-16
NZ516536A (en) 2003-09-26
EP1200129A1 (en) 2002-05-02
CA2378894C (en) 2005-11-22
IL147242A (en) 2008-12-29
CY1108801T1 (el) 2012-05-23
ZA200200026B (en) 2003-04-02
BR0012439A (pt) 2002-04-02
SK532002A3 (en) 2002-05-09
ATE411047T1 (de) 2008-10-15
CZ302919B6 (cs) 2012-01-18
CZ200271A3 (cs) 2002-04-17
AR024715A1 (es) 2002-10-23
JP2003504416A (ja) 2003-02-04
MXPA02000501A (es) 2002-07-02
BG65656B1 (bg) 2009-05-29
NO20020134L (no) 2002-01-11
HUP0202229A2 (hu) 2002-11-28
NO20020134D0 (no) 2002-01-11
CA2378894A1 (en) 2001-01-25
PL352183A1 (en) 2003-08-11

Similar Documents

Publication Publication Date Title
PT1226188E (pt) Processo de preparacao de aductos de mannich contendo poliisobutileno fenol
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1163207T3 (da) Forbedret fremgangsmåde til fremstillingen af ikke-hygroskopiske salte af L(-)-carnitin
ATE537831T1 (de) Orale aripiprazol-lösung
DE60006831D1 (de) Verbessertes schwenkrotor-verwandlungsflugzeug
NO20024175D0 (no) Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
ATE485823T1 (de) Kombinationspräparate enthaltend (e)-7-ä4-(4- fluorophenyl)-6-isopropyl-2-
DK1392307T3 (da) Tartratsalte af 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaen
NO20032187L (no) Heterocyklylalkylpiperidinderivater, deres fremstilling samt preparater inneholdende forbindelsene
NO20022330D0 (no) Analgesiske preparater inneholdende buprenorfin
DK1210085T3 (da) Farmaceutiske oplösninger af levosimendan
DK1282616T3 (da) Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter
ATE319461T1 (de) Simethicon enthaltendes abführmittel
NO20023482D0 (no) Fremgangsmåte for behandling av stoffmisbruk
NO20031144L (no) Klargjöringssystem for konsentriske rör
DK1165138T3 (da) Programmeret, kontrolleret ovarial stimulationsprotokol ved anvendelse af orale svangerskabsforebyggende midler
DK1187833T3 (da) Fremgangsmåde til fremstilling af thiamethoxam
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
DK1200129T3 (da) Smagsmaskering af orale, flydende quinolonfremstillinger ved anvendelse af ionbytterharpikser
NO20013145D0 (no) Anvendelse av Na-H-bytter-inhibitorer for fremstilling av medikamenter
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
NO20040205L (no) Farmasøytiske preparater inneholdende ionebytterharpikser belagt med virksomt stoff
DK1203000T3 (da) Fremgangsmåde til fremstilling af phosphonomethylglycin
DK1294694T3 (da) Fremgangsmåde til fremstilling af quinolinderivater